97 related articles for article (PubMed ID: 1549357)
21. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea.
Song BC; Kim H; Kim SH; Cha CY; Kook YH; Kim BJ
J Med Virol; 2005 Jan; 75(1):13-9. PubMed ID: 15543574
[TBL] [Abstract][Full Text] [Related]
22. Activation of the HTLV-I long terminal repeat by the hepatitis B virus X protein.
Marriott SJ; Lee TH; Slagle BL; Butel JS
Virology; 1996 Oct; 224(1):206-13. PubMed ID: 8862415
[TBL] [Abstract][Full Text] [Related]
23. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic potential of hepatitis B virus.
Koike K; Shirakata Y; Yaginuma K; Arii M; Takada S; Nakamura I; Hayashi Y; Kawada M; Kobayashi M
Mol Biol Med; 1989 Apr; 6(2):151-60. PubMed ID: 2615644
[TBL] [Abstract][Full Text] [Related]
25. Human hepatitis B virus X protein induces apoptosis in HepG2 cells: role of BH3 domain.
Lu YW; Chen WN
Biochem Biophys Res Commun; 2005 Dec; 338(3):1551-6. PubMed ID: 16274670
[TBL] [Abstract][Full Text] [Related]
26. [Clone of hepatitis B virus X gene and its protein expression].
Tang SG; Yang BC
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):525-8. PubMed ID: 16320580
[TBL] [Abstract][Full Text] [Related]
27. Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues.
Takada S; Koike K
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5628-32. PubMed ID: 2165598
[TBL] [Abstract][Full Text] [Related]
28. X protein of hepatitis B virus resembles a serine protease inhibitor.
Takada S; Koike K
Jpn J Cancer Res; 1990 Dec; 81(12):1191-4. PubMed ID: 2125986
[TBL] [Abstract][Full Text] [Related]
29. [Association of human hepatitis B virus (HBV) X protein and hRPB5, a subunit of RNA polymerases, and X transactivation].
Murakami S
Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):75-81. PubMed ID: 12442364
[No Abstract] [Full Text] [Related]
30. [Transactivation function of X gene-cellular gene fusion product or 3' truncated pre S2/S gene-cellular gene fusion product from integrated hepatitis B virus DNA].
Mita E; Hayashi N; Kamada T
Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):89-93. PubMed ID: 12442366
[No Abstract] [Full Text] [Related]
31. Biochemistry and functions of hepatitis B virus X protein.
Koike K; Takada S
Intervirology; 1995; 38(1-2):89-99. PubMed ID: 8666528
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of enhancer domains responsive to trans-activation by the X gene of human hepatitis B virus.
Goodarzi G; Ohno H; Adams R; Darabi A; Tewari A; Watabe M; Watabe K
Arch Virol; 1990; 114(3-4):237-42. PubMed ID: 2241574
[TBL] [Abstract][Full Text] [Related]
33. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.
Siddiqui A; Gaynor R; Srinivasan A; Mapoles J; Farr RW
Virology; 1989 Apr; 169(2):479-84. PubMed ID: 2705309
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus X protein produced in Escherichia coli is biologically functional.
Jameel S; Siddiqui A; Maguire HF; Rao KV
J Virol; 1990 Aug; 64(8):3963-6. PubMed ID: 2196386
[TBL] [Abstract][Full Text] [Related]
35. trans-activation by the hepatitis B virus X protein shows cell-type specificity.
Seto E; Zhou DX; Peterlin BM; Yen TS
Virology; 1989 Dec; 173(2):764-6. PubMed ID: 2596037
[TBL] [Abstract][Full Text] [Related]
36. An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity.
Ritter SE; Whitten TM; Quets AT; Schloemer RH
Virology; 1991 Jun; 182(2):841-5. PubMed ID: 2024502
[TBL] [Abstract][Full Text] [Related]
37. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator.
Rossner MT
J Med Virol; 1992 Feb; 36(2):101-17. PubMed ID: 1583465
[No Abstract] [Full Text] [Related]
38. Artificial transcriptional activation domains.
Lum JK; Mapp AK
Chembiochem; 2005 Aug; 6(8):1311-5. PubMed ID: 15973758
[No Abstract] [Full Text] [Related]
39. Hepadnaviral X Protein:Review of Recent Progress.
Yen TS
J Biomed Sci; 1996 Jan; 3(1):20-30. PubMed ID: 11725079
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the prevalence and impact of anemia on women hospitalized for gynecologic conditions associated with heavy uterine bleeding.
Morrison J; Patel ST; Watson W; Zaidi QR; Mangione A; Goss TF
J Reprod Med; 2008 May; 53(5):323-30. PubMed ID: 18567277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
